Q4 2014 13F Holders as of 31 Dec 2014
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
80,437,135
-
Number of holders
-
131
-
Total 13F shares, excl. options
-
28,362,106
-
Shares change
-
+3,831,621
-
Total reported value, excl. options
-
$1,468,602,926
-
Value change
-
+$198,969,370
-
Put/Call ratio
-
144%
-
Number of buys
-
90
-
Number of sells
-
-28
-
Price
-
$51.77
Significant Holders of PTC THERAPEUTICS, INC. - Common Stock (PTCT) as of Q4 2014
140 filings reported holding PTCT - PTC THERAPEUTICS, INC. - Common Stock as of Q4 2014.
PTC THERAPEUTICS, INC. - Common Stock (PTCT) has 131 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 28,362,106 shares
of 80,437,135 outstanding shares and own 35.3% of the company stock.
Largest 10 shareholders include FMR LLC (5,040,381 shares), WELLINGTON MANAGEMENT GROUP LLP (2,333,209 shares), BROOKSIDE CAPITAL MANAGEMENT LLC (2,081,932 shares), BB Biotech AG (1,227,912 shares), CREDIT SUISSE AG/ (1,183,152 shares), VANGUARD GROUP INC (1,175,176 shares), Sectoral Asset Management Inc (1,135,130 shares), BlackRock Fund Advisors (1,089,388 shares), GRANAHAN INVESTMENT MANAGEMENT INC/MA (869,101 shares), and WESTFIELD CAPITAL MANAGEMENT CO LP (731,310 shares).
This table shows the top 131 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.